ReviewFrontiers in immunology2023
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.
Bryan Gardam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it